Literature DB >> 183627

Pathogenetic mechansims of recurrent herpes simplex virus infections.

R J Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 183627     DOI： 10.1007/bf01317829

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  82 in total

Review 1.  LATENT HERPES SIMPLEX INFECTION IN MAN.

Authors:  T F PAINE
Journal:  Bacteriol Rev       Date:  1964-12

2.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

3.  Herpes simplex encephalitis in Hodgkins disease. Isolation of drug-sensitive virus from brain following unsuccessful treatment with idoxuridine.

Authors:  H S Heineman; F A Breen
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

4.  Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection.

Authors:  A B Nesburn; M L Cook; J G Stevens
Journal:  Arch Ophthalmol       Date:  1972-10

5.  Treatment of labial herpes.

Authors:  G R Nugent; S M Chou
Journal:  JAMA       Date:  1973-04-02       Impact factor: 56.272

6.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Herpes-simplex virus from trigeminal ganglion.

Authors:  S Rodda; I Jack; D O White
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

8.  "Treatment-resistance" to idoxuridine in herpetic keratitis.

Authors:  V R Coleman; E Tsu; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

9.  Herpes virus in the lacrimal gland, conjunctiva and cornea of man--a chronic infection.

Authors:  H E Kaufman; D C Brown; E D Ellison
Journal:  Am J Ophthalmol       Date:  1968-01       Impact factor: 5.258

10.  Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.

Authors:  T Lehner; J M Wilton; E J Shillitoe
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321
View more
  13 in total

Review 1.  Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

Authors:  D Pavan-Langston
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  Ophthaproblem. Dendrite secondary to herpetic keratitis.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 3.  Persistence in herpes simplex virus infections.

Authors:  M Longson
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

Review 4.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

Authors:  H J Zweerink; D Martinez; R J Lynch; L W Stanton
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

6.  Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.

Authors:  P A Asbell
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 7.  Epigenetics and Genetics of Viral Latency.

Authors:  Paul M Lieberman
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

8.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Neural changes in recurrent genital infection of infectious bovine rhinotracheitis virus in calves treated with dexamethasone.

Authors:  M Narita; S Inui; Y Yabuki; K Namba; Y Shimizu
Journal:  Br J Exp Pathol       Date:  1979-04

10.  Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.

Authors:  P H Lee; M H Su; E R Kern; W I Higuchi
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.